Prevalence of and relevant factors for depression and anxiety symptoms among pregnant women on the eastern seaboard of China in the post-COVID-19 era: a cross-sectional study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Pregnant Women*/psychology ; COVID-19*/epidemiology; Female ; Pregnancy ; Humans ; Cross-Sectional Studies ; Depression/psychology ; Prevalence ; Anxiety/psychology ; China/epidemiology
    • Abstract:
      Background: Antenatal depression and anxiety symptoms may have negative consequences for both mothers and offspring, and upward trends in the prevalence of these symptoms were especially apparent during the COVID-19 epidemic. The purpose of this study was to evaluate the prevalence of and relevant factors influencing depressive and anxiety symptoms in Chinese pregnant women in the post-COVID-19 era.
      Methods: We conducted an online survey of 1,963 pregnant women in Jiangsu Province, using a cross-sectional design, and collected their general demographic data. The nine-item Patient Health Questionnaire 9 (PHQ-9) was used to evaluate depression symptoms, and the seven-item Generalized Anxiety Disorder 7 (GAD-7) was used to measure anxiety symptoms.
      Results: The prevalence of reported antenatal depressive symptoms, anxiety symptoms, and depression combined with anxiety symptoms was 25.2%, 27.9%, and 18.6%, respectively. Of the respondents, the prevalence of moderate to severe depression, and anxiety was 7.9% and 7.7%, respectively. Binary logistic regression analysis demonstrated that age, low level of education, rural area, unemployment, pregnancy complications, poor marital relationship, and fair household income were positively association with both depressive and anxiety symptoms (all P < 0.05). The proportion of women reporting anxiety symptoms in the third trimester was 1.91-fold higher than in first trimester. Parity was a relevant factor for depression and anxiety symptoms (all P < 0.05).
      Conclusions: In the post-COVID-19 era, the prevalence of depression and anxiety symptoms in pregnant women was higher than expected, and it is vital to establish hospital, community, and family psychological health screening systems based on relevant factors and enhance early preventive measures.
      (© 2023. BioMed Central Ltd., part of Springer Nature.)
    • References:
      Arch Public Health. 2022 Jan 20;80(1):34. (PMID: 35057865)
      BMC Health Serv Res. 2022 May 13;22(1):641. (PMID: 35562791)
      Int J Environ Res Public Health. 2021 Jun 24;18(13):. (PMID: 34202666)
      Lancet Psychiatry. 2022 Feb;9(2):137-150. (PMID: 35026139)
      Lancet Psychiatry. 2016 Oct;3(10):973-982. (PMID: 27650773)
      Asian J Psychiatr. 2021 Feb;56:102533. (PMID: 33418283)
      J Affect Disord. 2020 Dec 1;277:5-13. (PMID: 32777604)
      J Med Internet Res. 2021 Jan 22;23(1):e24495. (PMID: 33302251)
      Transl Psychiatry. 2021 Oct 2;11(1):505. (PMID: 34601497)
      Lancet. 2021 Nov 6;398(10312):1700-1712. (PMID: 34634250)
      J Affect Disord. 2017 Feb;209:195-200. (PMID: 27930912)
      J Gen Intern Med. 2001 Sep;16(9):606-13. (PMID: 11556941)
      J Affect Disord. 2019 May 1;250:57-64. (PMID: 30831542)
      Arch Intern Med. 2006 May 22;166(10):1092-7. (PMID: 16717171)
      J Affect Disord. 2020 Jun 1;270:85-89. (PMID: 32275225)
      Int J Methods Psychiatr Res. 2023 Sep;32(3):e1956. (PMID: 36461893)
      Psychiatry Res. 2019 Feb;272:316-318. (PMID: 30597383)
      Annu Rev Psychol. 2011;62:531-58. (PMID: 21126184)
      BMC Pregnancy Childbirth. 2022 Feb 11;22(1):114. (PMID: 35148708)
      Einstein (Sao Paulo). 2022 May 06;20:eCE6760. (PMID: 35584448)
      Acta Obstet Gynecol Scand. 2021 Jul;100(7):1219-1229. (PMID: 33475148)
      J Psychiatr Res. 2020 Jul;126:134-140. (PMID: 31439359)
      BMC Pregnancy Childbirth. 2018 Jul 4;18(1):288. (PMID: 29973235)
      Psychiatry Res. 2021 Jun;300:113912. (PMID: 33836471)
      J Reprod Infant Psychol. 2018 Nov;36(5):519-529. (PMID: 30092662)
      J Youth Adolesc. 2017 Jan;46(1):63-77. (PMID: 27817098)
      Early Hum Dev. 2021 Jun;157:105364. (PMID: 33813323)
      Int J Dev Neurosci. 2017 Aug;60:1-7. (PMID: 28389369)
      Front Pharmacol. 2020 Dec 03;11:559601. (PMID: 33519430)
      Front Public Health. 2022 Jun 13;10:906788. (PMID: 35769778)
      J Psychosom Obstet Gynaecol. 2022 Sep;43(3):315-326. (PMID: 34165032)
      BMC Pregnancy Childbirth. 2022 Mar 28;22(1):260. (PMID: 35351030)
      Heliyon. 2022 Oct 03;8(10):e10902. (PMID: 36210864)
      BMC Pregnancy Childbirth. 2021 Dec 4;21(1):807. (PMID: 34863117)
      CMAJ. 2017 Aug 28;189(34):E1085-E1092. (PMID: 28847780)
      Infant Behav Dev. 2011 Feb;34(1):1-14. (PMID: 20970195)
      Prim Care Companion CNS Disord. 2021 Dec 02;23(6):. (PMID: 34861747)
      Adv Exp Med Biol. 2020;1191:219-235. (PMID: 32002932)
      Int J Environ Res Public Health. 2021 Mar 08;18(5):. (PMID: 33800371)
      Gen Hosp Psychiatry. 2014 Sep-Oct;36(5):539-44. (PMID: 25023953)
      Front Psychiatry. 2022 Oct 06;13:972628. (PMID: 36276320)
      BMC Psychiatry. 2019 Apr 3;19(1):104. (PMID: 30943938)
      J Affect Disord. 2021 Feb 15;281:567-573. (PMID: 33261931)
      BMC Pregnancy Childbirth. 2022 Sep 13;22(1):704. (PMID: 36100878)
      BMJ. 2022 Feb 16;376:e068993. (PMID: 35172971)
      Arch Womens Ment Health. 2022 Dec;25(6):1067-1078. (PMID: 36151337)
      BMC Public Health. 2020 Feb 4;20(1):173. (PMID: 32019560)
      BMC Psychiatry. 2020 Jun 9;20(1):291. (PMID: 32517743)
      Psychiatr Danub. 2018 Mar;30(1):85-90. (PMID: 29546863)
      Cureus. 2022 Jul 23;14(7):e27174. (PMID: 36039202)
      J Affect Disord. 2020 Dec 1;277:1022-1037. (PMID: 33065811)
      J Affect Disord. 2021 Aug 1;291:243-251. (PMID: 34051531)
      Eur Child Adolesc Psychiatry. 2020 Jun;29(6):749-758. (PMID: 32363492)
      Acta Obstet Gynecol Scand. 2020 Jul;99(7):848-855. (PMID: 32449178)
      J Affect Disord. 2022 Jun 1;306:71-79. (PMID: 35306121)
      Int J Adolesc Med Health. 2022 Dec 21;35(2):189-195. (PMID: 36539995)
      JAMA Pediatr. 2021 Aug 1;175(8):817-826. (PMID: 33885740)
      J Am Acad Child Adolesc Psychiatry. 2018 Sep;57(9):645-657.e8. (PMID: 30196868)
      Disaster Med Public Health Prep. 2022 Apr;16(2):449-454. (PMID: 32907687)
      J Affect Disord. 2020 Jun 15;271:178-184. (PMID: 32479314)
      J Affect Disord. 2021 Mar 1;282:98-103. (PMID: 33401129)
      J Clin Psychiatry. 2013 Apr;74(4):e321-41. (PMID: 23656857)
      J Med Internet Res. 2021 Jan 18;23(1):e18722. (PMID: 33347423)
      Women Birth. 2015 Sep;28(3):179-93. (PMID: 25765470)
      J Perinat Med. 2020 Nov 26;48(9):965-970. (PMID: 32887191)
      J Psychiatr Res. 2017 Aug;91:1-13. (PMID: 28284107)
      Front Psychol. 2021 Oct 18;12:701629. (PMID: 34733199)
      JAMA. 2003 Jun 18;289(23):3095-105. (PMID: 12813115)
      Arch Womens Ment Health. 2020 Dec;23(6):757-765. (PMID: 32989598)
    • Contributed Indexing:
      Keywords: Antenatal anxiety; Antenatal depression; Post-COVID-19 era; Pregnant women; Prevalence; Risk factors
    • Publication Date:
      Date Created: 20230807 Date Completed: 20230809 Latest Revision: 20231123
    • Publication Date:
      20231123
    • Accession Number:
      PMC10405434
    • Accession Number:
      10.1186/s12888-023-05059-2
    • Accession Number:
      37550657